[Federal Register Volume 62, Number 224 (Thursday, November 20, 1997)]
[Notices]
[Page 62065]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-30421]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
National Institute on Drug Abuse (NIDA) Initial Review Group and
Special Emphasis Panel meetings.
Purpose/Agenda: To review and evaluate grant applications and
contract proposals.
Name of Committee: AIDS Behavioral Research Subcommittee.
Date: December 2-3, 1997.
Time: 8:30 a.m.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center,
Bethesda, MD 20814.
Contact Person: Mary C. Custer, Ph.D., Scientific Review
Administrator, Office of Extramural Program Review, National
Institute on Drug Abuse, 5600 Fishers Lane, Room 10-22, Telephone
(301) 443-2620.
Name of Committee: NIDA Special Emphasis Panel (Contract
Review--``Quantitative Analysis of and Method Development for
Cannabinoids, Endogenous Compounds, and Other Drugs of Abuse and
Related Compounds by Radioimmunoassay or Related Methods'').
Date: December 19, 1997.
Time: 10:30 a.m.
Place: Office of Extramural Program Review, National Institute
on Drug Abuse, NIH, 5600 Fishers Lane, Room 10-42, Rockville, MD
20857 (Telephone Conference).
Contact Person: Mr. Eric Zatman, Contract Review Specialist,
Office of Extramural Program Review, National Institute on Drug
Abuse, 5600 Fishers Lane, Room 10-42, Rockville, MD 20857, Telephone
(301) 443-1644.
The meetings will be closed in accordance with provisions set
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The
applications and/or proposals and the discussions could reveal
confidential trade secrets or commercial property such as patentable
material and personal information concerning individuals associated
with the applications and/or proposals, the disclosure of which
would constitute a clearly unwarranted invasion of personal privacy.
(Catalog of Federal Domestic Assistance Program Numbers: 93.277,
Drug Abuse Scientist Development, Research Scientist Development,
and Research Scientist Awards; 93.278, Drug Abuse National Research
Service Awards for Research Training; 93.279, Drug Abuse Research
Programs, National Institutes of Health)
Dated: November 13, 1997.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 97-30421 Filed 11-19-97; 8:45 am]
BILLING CODE 4140-01-M
